Personalized Medicine beyond Low-Density Lipoprotein Cholesterol to Combat Residual Risk for Coronary Artery Disease.

Personalized Medicine beyond Low-Density Lipoprotein Cholesterol to Combat Residual Risk for Coronary Artery Disease. J Atheroscler Thromb. 2021 Feb 06;: Authors: Tada H PMID: 33551446 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/33551446?dopt=Abstract

Source: Journal of Atherosclerosis and Thrombosis - February 9, 2021 Category: Cardiology Tags: J Atheroscler Thromb Source Type: research

More News: Cardiology | Cholesterol | Thrombosis